Roche manufactures afucosylated monoclonal antibodies in CHO cells lines, where the cell has been engineered to overexpress an enzyme called GnTIII.
Kyowa Hakko Kirin manufactures afucosylated monoclonal antibodies in CHO cells in which the endogenous FUT8 gene has been knocked out.